Cargando…
Theranostic application of miR-429 in HER2+ breast cancer
Human epidermal growth factor receptor 2 (HER2) is overexpressed/amplified in one third of breast cancers (BCs), and is associated with the poorer prognosis and the higher metastatic potential in BC. Emerging evidences highlight the role of microRNAs (miRNAs) in the regulation of several cellular pr...
Autores principales: | Cava, Claudia, Novello, Chiara, Martelli, Cristina, Lo Dico, Alessia, Ottobrini, Luisa, Piccotti, Francesca, Truffi, Marta, Corsi, Fabio, Bertoli, Gloria, Castiglioni, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929607/ https://www.ncbi.nlm.nih.gov/pubmed/31903105 http://dx.doi.org/10.7150/thno.36274 |
Ejemplares similares
-
Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021) -
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
por: Bertoli, Gloria, et al.
Publicado: (2016) -
MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016) -
CMA mediates resistance in breast cancer models
por: Lo Dico, Alessia, et al.
Publicado: (2023) -
Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy
por: Cava, Claudia, et al.
Publicado: (2018)